facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
1/2019
vol. 106
 
Share:
Send email
Share:
abstract:
Original paper

Serum concentrations of adipokines in psoriasis and cardiometabolic risk

Anna Pasierb
1
,
Radosław Pietrzak
1
,
Paweł Rykowski
1
,
Zbigniew Bartoszewicz
2
,
Małgorzata Stakun
1
,
Lidia Rudnicka
1
,
Joanna Czuwara
1

  1. Department of Dermatology, Medical University of Warsaw, Poland
  2. Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Poland
Dermatol Rev/Przegl Dermatol 2019, 106, 16–24
DOI: https://doi.org/10.5114/dr.2019.83441
Online publish date: 2019/03/19
View full text Get citation
 
PlumX metrics:
Introduction
Psoriasis is associated with symptoms of the metabolic syndrome. Adipokines are bioactive mediators secreted by adipose tissue. They influence inflammatory reactions, insulin resistance, diabetes and atherosclerosis. Alterations in serum levels of some adipokines have been reported in patients with psoriasis.

Objective
A cross-sectional study was performed to better understand the role of adipokines in psoriasis, by assessing their levels and relationship with disease severity.

Material and methods
Serum fasting levels of six different adipokines – adiponectin, leptin, visfatin, resistin, chemerin, and retinol binding protein 4 (RBP4) – were measured in 42 patients with psoriasis and correlated with the Psoriasis Area and Severity Index, body surface area, body mass index, waist-hip ratio and lipid parameters.

Results
The results showed that adipokines did not correlate with psoriasis severity, with the exception of RBP4 concentration, which showed a statistically significant difference between patients with mild, moderate and severe psoriasis. RBP4 was elevated in moderate and severe psoriasis, what can correspond with the therapeutic effect of retinoids in psoriasis depending on fat tissue capacity. Significant negative correlations was observed between adiponectin/leptin ratio and following parameters: with body mass index (p < 0.0001), waist-hip ratio (p = 0.04) and visceral fat (p = 0.0001) and a correlation with HDL cholesterol (p = 0.0005). A total of 83.3% (35/42) showed an adiponectin/leptin ratio below 0.5, which isindicative of high cardiometabolic risk.

Conclusions
To the best of our knowledge, this is the first study assessing six different adipokines in sera of patients with psoriasis and their correlation with disease severity and metabolic syndrome components, showing increased cardiovascular risk in patients with psoriasis, based on the adiponectin/leptin ratio.

keywords:

adipokines, cardiometabolic risk, obesity, psoriasis severity
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Alergologia – kompendium


Indeks osobowy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.